Eleanor Knight

1.7k total citations · 1 hit paper
8 papers, 744 citations indexed

About

Eleanor Knight is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Eleanor Knight has authored 8 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Biomedical Engineering. Recurrent topics in Eleanor Knight's work include 3D Printing in Biomedical Research (3 papers), DNA Repair Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). Eleanor Knight is often cited by papers focused on 3D Printing in Biomedical Research (3 papers), DNA Repair Mechanisms (2 papers) and PARP inhibition in cancer therapy (2 papers). Eleanor Knight collaborates with scholars based in United Kingdom, United States and Sweden. Eleanor Knight's co-authors include Stefan Przyborski, Christopher J. Lord, Rebecca Marlow, Andrew Tutt, Luned Badder, Kurt D. Hankenson, Lu Yu, Shudong Li, Stephen J. Pettitt and Tanaji T. Talele and has published in prestigious journals such as Nature, Nature Cell Biology and Annals of the Rheumatic Diseases.

In The Last Decade

Eleanor Knight

8 papers receiving 739 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro

2014 412 citations Eleanor Knight, Stefan Przyborski Journal of Anatomy profile →

Peers

Countries citing papers authored by Eleanor Knight

Since Specialization

Citations

This map shows the geographic impact of Eleanor Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor Knight more than expected).

Fields of papers citing papers by Eleanor Knight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleanor Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor Knight. The network helps show where Eleanor Knight may publish in the future.

Co-authorship network of co-authors of Eleanor Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor Knight. A scholar is included among the top collaborators of Eleanor Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor Knight. Eleanor Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin 2022 ·Nature Cell Biology ·Dragomir B. Krastev, Shudong Li, Yilun Sun, Andrew J. Wicks, (unknown), Daniel Weekes, Luned Badder, Eleanor Knight, Rebecca Marlow, Mercedes Pardo, Lu Yu, Tanaji T. Talele, Jiří Bártek, Jyoti S. Choudhary, Yves Pommier, Stephen J. Pettitt, Andrew Tutt, Kristijan Ramadan, Christopher J. Lord	92
2	Synovial fibroblasts assume distinct functional identities and secrete R-spondin 2 in osteoarthritis 2022 ·Annals of the Rheumatic Diseases ·Alexander J. Knights, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eleanor Knight, (unknown), (unknown), Chia‐Lung Wu, Kurt D. Hankenson, Tristan Maerz	73
3	Using Advanced Cell Culture Techniques to Differentiate Pluripotent Stem Cells and Recreate Tissue Structures Representative of Teratoma Xenografts 2021 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), Dominic D. G. Owens, (unknown), Eleanor Knight, Stefan Przyborski	3
4	Improvements in National Code Red transfusion practice in Scotland after adoption of recommendations from the Scottish National Code Red 2015 review 2020 ·Injury ·Matthew J. Reed, (unknown), (unknown), (unknown), Susan Henderson, Eleanor Knight, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Megan Rowley, (unknown), (unknown)	3
5	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer 2020 ·Nature ·(unknown), Bramwell G. Lambrus, Rebecca Marlow, (unknown), (unknown), (unknown), Phillip M. Scott, (unknown), Elizabeth M. Park, (unknown), Daniela Moralli, Eleanor Knight, Luned Badder, Daniela Novo, Syed Haider, Catherine Green, Andrew Tutt, Christopher J. Lord, J. Ross Chapman, Andrew J. Holland	77
6	SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition 2018 ·Oncotarget ·Jeffrey C. Francis, (unknown), Jian Ning, Eleanor Knight, Johann S. de Bono, Amanda Swain	26
7	Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro breakdown → 2014 ·Journal of Anatomy ·Eleanor Knight, Stefan Przyborski	412
8	Alvetex®: Polystyrene Scaffold Technology for Routine Three Dimensional Cell Culture 2010 ·Methods in molecular biology ·Eleanor Knight, (unknown), (unknown), Stefan Przyborski	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact